Austrian research team identifies new therapeutic target for leukemic cutaneous T-cell lymphoma
Leukemic cutaneous T-cell lymphoma (L-CTCL) is a rare type of skin cancer that presents varied..
"For Women in Science" grants for young female researchers from MedUni Vienna
(Vienna, 30.11.2022) Four female scientists were honored for their research contributions as part..
Thomas Vogl receives prestigious ERC Starting Grant from the EU
(Vienna, 22.11.2022) Thomas Vogl, research group leader at MedUni Vienna's Center for Cancer..
CCR Lecture Series, 18. Nov. 2022
Andreas Reinisch: "Genome engineering of hematopoietic stem cells to model clonal hematopoiesis and..
CCR Lecture Series, 28. Okt. 2022
Mazda Jenab: "Diet, Lifestyle and Metabolic Dysfunction in Colorectal Cancer Development"
Das war der Krebsforschungslauf 2022
Wir bedanken uns bei allen Läufer:innen, Sponsor:innen und Unterstützer:innen!
Running for cancer research on 8 October from 10 am to 2 pm
(Vienna, 29.09.2022) Since 2007, more than 60 scientific projects pertaining to tumours have been..
Impromptu Seminar - 7. Okt. 2022
Arno R. Bourgonje: "Multimodal discovery of biomarker signatures for inflammatory bowel diseases..
Check handover for the Cancer Research Run 2021
(Vienna, 12.07.2022) Kuehne+Nagel is a long-standing partner of the Cancer Research Run and has..
16th Cancer Research Run on October 8, 2022
(Vienna, 05.07.2022) The 16th cancer research run is back on the original running route at the..
Generous donation to the Institute for Cancer Research
Today we had a special guest at the Institute for Cancer Research! Mr. Ferdinand Molzer, a longtime and loyal sponsor made a generous donation to the Institute for Cancer Research for our research projects.
Over a good cup of coffee with the head of the institute Univ.-Prof. Mag. Dr. Maria Sibilia he talked about his time as a firefighter in action for the city of Vienna. After many decades of great commitment to society, Mr. Molzer is now in a well-deserved retirement.
We are very happy that Mr. Molzer visited us and we wish him all the best for the future!
back to: Cancer Research
